EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
ABBV Maintained by Evercore ISI Group -- Price Target Raised to $236
10 Years, Zero Regrets: The Dividend Stocks I Keep Buying
Truist Financial Corp Grows Position in AbbVie Inc. $ABBV
Ironwood Survey Findings at DDW 2026 Underscore Need for Therapies that Address Multiple Dimensions of Total Parenteral Nutrition (TPN) Burden in Short Bowel Syndrome (SBS) | Morningstar
SKYRIZI® (risankizumab) Secures Listing on Ontario and Alberta Formularies in Ulcerative Colitis
SKYRIZI® Secures Listing on Ontario and Alberta Formularies in Ulcerative Colitis | INN
AbbVie Inc. $ABBV Shares Sold by PKO Investment Management Joint Stock Co
5,538 Shares in AbbVie Inc. $ABBV Acquired by Legacy Edge Advisors LLC
Assessing AbbVie (ABBV) Valuation After Raised Guidance And Strong Q1 Growth Drivers
AbbVie (NYSE:ABBV) Given Buy Rating at Guggenheim - Stock Observer
Robertson Stephens Wealth Management LLC Boosts Holdings in AbbVie Inc. $ABBV - Stock Observer
PFA Pension Forsikringsaktieselskab Invests $242.03 Million in AbbVie Inc. $ABBV - Stock Observer
AbbVie (NYSE:ABBV) Upgraded to "Strong-Buy" at DZ Bank - Daily Political
AbbVie Inc. (NYSE:ABBV) Given Average Rating of "Moderate Buy" by Brokerages
Real-world effectiveness and safety of blinatumomab in adults with B-cell precursor acute lymphoblastic leukaemia across 13 European countries
AbbVie (NYSE:ABBV) Updates Q2 2026 Earnings Guidance
AbbVie (NYSE:ABBV) Trading Up 3.3% After Earnings Beat - Daily Political
ABBV Reiterated by Guggenheim -- Price Target Maintained at $249
AbbVie (NYSE:ABBV) Stock Price Down 2.2% - Here's What Happened - Stock Observer
Oppenheimer & Co. Inc. Sells 8,094 Shares of AbbVie Inc. $ABBV
Discover 3 Stocks That Might Be Trading Below Estimated Value
Fifth Third Bancorp Grows Stock Holdings in AbbVie Inc. $ABBV
Is AbbVie Inc. (ABBV) One of the Best Drug Stocks to Buy According to Analysts?
AbbVie Inc. $ABBV Shares Bought by Fifth Third Bancorp - Daily Political
New York State Teachers Retirement System Sells 39,154 Shares of AbbVie Inc. $ABBV - Zolmax
ABBV Maintained by Canaccord Genuity -- Price Target Raised to $265
Tumor-localized CD40 agonism with MP0317, a FAP x CD40 DARPin, reprograms the tumor microenvironment in patients with advanced solid tumors: an open-label, nonrandomized, dose-escalation phase 1 study
A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients
Canaccord Genuity Group Issues Positive Forecast for AbbVie (NYSE:ABBV) Stock Price
Bank of America Upgrades AbbVie (ABBV) on Skyrizi Strength, Lifts PT
Top Medical Stocks To Consider - April 27th - Stock Observer
AbbVie (NYSE:ABBV) Shares Up 3.8% Following Analyst Upgrade
AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec | Taiwan News | May. 1, 2026 03:00
ABBV Maintained by Morgan Stanley -- Price Target Raised to $278
New York State Teachers Retirement System Reduces Stock Holdings in AbbVie Inc. $ABBV - Daily Political
AbbVie (NYSE:ABBV) Price Target Raised to $278.00
Best Dividend Stocks To Follow Today - April 30th - Stock Observer
AbbVie's (ABBV) "Overweight" Rating Reaffirmed at Cantor Fitzgerald
Research Analysts' Price Target Changes for April 30th (ABBV, ACGL, AER, AMP, AMZN, ARE, AVY, BAND, BELFB, BILL) - Stock Observer
Stock Analysts' Updated EPS Estimates for April 30th (ABBV, AIRJ, AMT, AMZN, APPN, BTU, CMG, CMRC, CSTM, DCC) - Stock Observer
AbbVie (NYSE:ABBV) Issues Quarterly Earnings Results - Daily Political
AbbVie Inc. $ABBV Shares Sold by State of New Jersey Common Pension Fund D
US Bancorp DE Sells 41,982 Shares of AbbVie Inc. $ABBV
AbbVie Inc. (NYSE:ABBV) Q1 2026 Earnings Call Transcript
Deoxycholic Acid Obesity Drugs Market Analysis Report 2026: $970 Mn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
AbbVie Exceeds Earnings Expectations with Surge in Skyrizi and Rinvoq Sales Amid Humira Decline, ETPharma
OSE Immunotherapeutics Reports Full Year 2025 Unaudited Consolidated Financial Results and 2026 Q1 Cash Position | Taiwan News | Apr. 30, 2026 13:30
Q1 2026 AbbVie Inc Earnings Call Transcript
AbbVie Q1 Earnings Call Highlights
AbbVie's patent on immunology therapy rejected
AbbVie (ABBV) Reports Strong Q1 2026 Results and Raises Full-Year Guidance
AbbVie (NYSE:ABBV) Trading 3.3% Higher - Time to Buy?
AbbVie Inc (ABBV) Shares Surge 3.1% -- What GF Score of 85 Tells
AbbVie (NYSE:ABBV) Posts Earnings Results, Misses Expectations By $0.36 EPS
ABBV Misses Q2 Revenue Expectations Slightly
Keybank National Association OH Raises Stake in AbbVie Inc. $ABBV - Daily Political
AbbVie raises outlook as blockbuster Skyrizi faces new rivals
AbbVie Raises 2026 Outlook To $14.28 As Q1 Earnings Beat Estimates
ABBV Shows Strong Fundamentals and Progress in Programs
AbbVie (ABBV) Raises Full-Year Earnings Outlook Following Q1 Revenue Beat
Top Dividend Stocks To Research - April 29th - Daily Political
Is AbbVie (ABBV) 1.6% Undervalued After Q1 2026? Adjusted EPS $2.65 Beats vs. $1. ...
AbbVie (ABBV) Reports Q1 Results with Revenue Beat and EPS Miss
AbbVie (ABBV) Stock Jumps on Strong Q1 Beat and Upgraded Full-Year Forecast
AbbVie Q1 Profit Down, Revenues Rise; Lifts FY26 Earnings View - Update
AbbVie Q1 26 Earnings Conference Call At 9:00 AM ET
AbbVie tops quarterly expectations as newer immunology drugs offset Humira decline
Keybank National Association OH Boosts Holdings in AbbVie Inc. $ABBV
AbbVie Seeks FDA Approval To Expand RINVOQ Use For Alopecia Areata
Federal judge strikes down North Dakota pharmaceutical law as unconstitutional
AbbVie (ABBV) Anticipates Strong Q1 Earnings and Robust Growth Drivers
AbbVie (ABBV) Reports Superior Efficacy of Rinvoq Over Humira in
AbbVie Inc. $ABBV Shares Sold by Vest Financial LLC
RINVOQ® (upadacitinib) Demonstrated Superiority Versus HUMIRA® (adalimumab) for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF inhibitor
EvolveImmune Therapeutics Announces Achievement of Preclinical Milestone in Collaboration with AbbVie
AbbVie Inc. $ABBV Shares Sold by Arlington Trust Co LLC
KTF Investments LLC Makes New Investment in AbbVie Inc. $ABBV - Daily Political
AbbVie Inc. $ABBV Shares Sold by Mitsubishi UFJ Trust & Banking Corp - Daily Political
AbbVie (ABBV) Maintains Dividend Strength as Core Drugs Drive Cash Flow
AbbVie Seeks FDA Approval for Subcutaneous Skyrizi (ABBV)
Is Bristol Myers Squibb the Best Bargain in Big Pharma?
AbbVie Submits Regulatory Application to FDA for SKYRIZI® Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease | INN
Comerica Bank Trims Stock Position in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Bought by D.A. Davidson & CO.
Anchyra Partners LLC Buys Shares of 5,056 AbbVie Inc. $ABBV
Piper Sandler Cuts PT on AbbVie Inc. (ABBV) Ahead of Quarterly Results
AbbVie Inc. (ABBV) Receives CRL from the FDA About the Biologics License Application for trenibotulinumtoxinE
ABBVIE SP. Z O.O. secures contract for Pharmaceutical products
Therapeutic targeting of BCL-2 during CART cell production augments potency through non-apoptotic adaptive changes
AbbVie Inc. $ABBV Shares Acquired by Vanguard Group Inc.
Top Pharmaceutical Stocks To Keep An Eye On - April 26th - Daily Political
AbbVie News
Why Oil Keeps Rising: Strait of Hormuz Crisis, Middle East Conflict, OPEC+ Strategy and More
Crypto market analysis: AAVE price AAVE/ZAR surges, what’s happening with the crypto market in South Africa?
Liquidity, Costs, and Execution: A Comparative Analysis of JSE and A2X for ZA Traders
Top Germany Utility Stocks Outlook: Analysis of E.ON SE (EOAN) Stock, RWE AG (RWE) Stock and EBK Stock
ETH Price Prediction 2026: Ethereum Sees $14.5B in 24-Hour Volume, What’s Next for ETHUSD?
Tech Giant Stock Analysis: How Microsoft (MSFT) Will Boost the AI Industry in 2026?
Mag 7 stocks analysis: What’s going on with Nvidia, Microsoft, Meta and the Rest?
Hang Seng Index drops below 26,000 points: What’s happening with the Hong Kong stock market?
Latest news
Show more
Commodity Market Today: UAE to Leave OPEC After Nearly 60 Years in Major Blow to Oil Cartel
Gold Price Today, April 30: XAUUSD Hits $4,575 Amid Escalating Global Economic Uncertainty
Apple (AAPL) Q2 FY26 is coming: What’s going on with the Apple Supply Chain Stocks?
Gold Price Today, April 29: Gold XAUUSD Holds at $4,702 as Overbought Signals Flash
Gold Price Today, April 28: XAUUSD Hits $4,702 as Safe-Haven Demand Remains Strong Amid Geopolitical Tensions
